Showing results (191-200 of 292) with videos related to

Sort By:
Pageof 30
Frontiers in Pharmacology|October 15, 2025
Preferences for gene therapy in Duchenne muscular dystrophy: insights from patient and caregiver interviews and attribute developmentThomas Desmet, Lauren Van Haesendonck, Sophie Vermeire, et al.
European Journal of Public Health|October 31, 2019
Cost-utility analysis of lifestyle interventions to prevent type 2 diabetes in women with prior gestational diabetesAmber Werbrouck, Masja Schmidt, Koen Putman, et al.
Clinical Pharmacology and Therapeutics|April 3, 2020
The Efficacy, Safety, and Immunogenicity of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic ReviewLiese Barbier, Hans C Ebbers, Paul Declerck, et al.
Frontiers in Pharmacology|July 23, 2016
Overcoming Barriers to the Market Access of Biosimilars in the European Union: The Case of Biosimilar Monoclonal AntibodiesEvelien Moorkens, Clara Jonker-Exler, Isabelle Huys, et al.
Diabetes Research and Clinical Practice|December 12, 2018
A systematic review on costs and cost-effectiveness of screening and prevention of type 2 diabetes in women with prior gestational diabetes: Exploring uncharted territoryAmber Werbrouck, Masja Schmidt, Koen Putman, et al.
Journal of Advanced Nursing|June 16, 2010
Increasing nurse staffing levels in Belgian cardiac surgery centres: a cost-effective patient safety intervention?Koen Van den Heede, Steven Simoens, Luwis Diya, et al.
BMC Health Services Research|September 29, 2022
Determinants of prescribing decisions for off-patent biological medicines in Belgium: a qualitative studyYannick Vandenplas, Steven Simoens, Philippe Van Wilder, et al.
Expert Review of Vaccines|August 13, 2024
The broader benefits of vaccines: methodologies for inclusion in economic evaluationSteven Simoens, Sandy Tubeuf, Nicolas Dauby, et al.
Drug Discovery Today|November 26, 2020
Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutionsEline van Overbeeke, Sissel Michelsen, Mondher Toumi, et al.
Frontiers in Pharmacology|February 4, 2025
Towards implementing new payment models for the reimbursement of high-cost, curative therapies in Europe: insights from semi-structured interviewsThomas Desmet, Sissel Michelsen, Elena Van den Brande, et al.
Pageof 30